Clinical Trial Update: The FLOT Regimen Conversion Therapy of Adenocarcinoma of the Stomach / Gastroesophageal [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial update for conversion therapy using the FLOT regimen in adenocarcinoma of the stomach and gastroesophageal junction; current status is …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Adenocarcinoma of the Stomach
• Gastroesophageal Junction Adenocarcinoma

Drugs mentioned

• 5-Fluorouracil (5-FU)
• DOCETAXEL (DOCETAXEL)
• Leucovorin (folinic acid)
• OXALIPLATIN (Oxaliplatin)

Snippet

Sponsor: Henan Cancer Hospital | Conditions: Adenocarcinoma of the Stomach / Gastroesophageal | Phase 2 | Status: UNKNOWN